# TuHURA Biosciences, Inc.: Form SCHEDULE 13D/A, filed Aug 28, 2026

- Company: [TuHURA Biosciences, Inc.](/companies/hura.md) (CIK 1498382)
- Form: SCHEDULE 13D/A
- Filed: 2026-08-28
- Accepted by EDGAR: Aug 28, 2026, 18:01 ET
- Period: not reported
- Accession: 0000897069-26-001732
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498382/000089706926001732/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498382/000089706926001732/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498382/000089706926001732/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 28, 2026.
Source: SEC EDGAR, the filing index for accession 0000897069-26-001732. Last ingested by Listed: Nov 6, 2026, 18:07 ET. No prices; not investment advice.
